Cited by 42Liver physiology and pathologyDrug-Induced Hepatotoxicity and ProtectionOrgan Transplantation Techniques and Outcomes

The DOI matches its Crossref record.

Continuous hepatocyte growth factor supply prevents lipopolysaccharide‐induced liver injury in rats

Abstract

We present a rat model in which continuous supply of hepatocyte growth factor (HGF) prevents liver injury induced by carbon tetrachloride (CCl4) and E. coli 011:B4 lipopolysaccharide (LPS). Rat fibroblasts genetically modified to secrete rat HGF were implanted in syngenic rat spleen 7 days before administration of the hepatotoxins. Rats with HGF-secreting fibroblasts in the spleen showed a dramatic resistance to CCl4- and LPS-induced liver injury. In the LPS-induced liver injury model, blood chemical analysis revealed that the increase in serum glutamic oxalacetic transaminase level and the decrease in blood sugar level were remarkably suppressed in rats with HGF-secreting cells in the spleen. Most importantly, their survival rate was greatly improved compared to other control groups of rats. Thus our results indicate a new role of HGF in liver protection during endotoxemia and convey important clinical implications for developing new therapeutic modalities in the treatment of liver failure caused by endotoxemia.

Overview

Integrity signals

Registry

Crossref · 10.1016/s0014-5793(97)00744-8

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Continuous introduction of rat HGF to animals through genetically modified fibroblasts significantly decreased liver injury following LPS injection.

    “when Kaido et al. continuously introduced rat HGF to animals through genetically modified fibroblasts, there was a significantly decreased liver injury following LPS injection [31].”

Citations

Cites

No references could be resolved yet.

Research works printed but not linked: 40

  1. 10.1016/0140-6736(91)91452-Z · DOI
  2. 10.7326/0003-4819-120-9-199405010-00009 · DOI
  3. 10.1146/annurev.me.38.020187.002221 · DOI
  4. 10.1073/pnas.91.4.1198 · DOI
  5. 10.1159/000227326 · DOI
  6. 10.1002/1097-0142(19910515)67:10 <2708::AID-CNCR2820671707>3.0.CO;2-A · DOI
  7. 10.1056/NEJM198809083191001 · DOI
  8. 10.1016/S0140-6736(88)91475-4 · DOI
  9. Metcalf D, 1987, Exp. Hematol., 15, 1
  10. 10.1182/blood.V70.5.1696.1696 · DOI
  11. 10.1073/pnas.84.8.2484 · DOI
  12. 10.1182/blood.V84.9.2960.2960 · DOI
  13. 10.1038/nm0495-353 · DOI
  14. 10.1016/0006-291X(84)91253-1 · DOI · Paper page
  15. 10.1002/jcp.1041190207 · DOI
  16. Matsumoto K, 1992, Crit. Rev. Oncog., 3, 27
  17. 10.1016/0304-419X(93)90015-5 · DOI
  18. 10.1002/hep.1840160520 · DOI
  19. 10.1073/pnas.91.10.4357 · DOI
  20. 10.1093/oxfordjournals.jbchem.a124958 · DOI
  21. 10.1073/pnas.87.8.3200 · DOI
  22. 10.1126/science.2144057 · DOI
  23. 10.1016/0042-6822(81)90168-9 · DOI
  24. 10.1016/0042-6822(73)90163-3 · DOI
  25. 10.1006/bbrc.1996.0001 · DOI
  26. Bosch M.A, 1988, Br. J. Exp. Pathol., 69, 805
  27. 10.4049/jimmunol.123.5.2133 · DOI
  28. 10.1007/BF00311988 · DOI
  29. 10.1016/0140-6736(91)91452-Z · DOI
  30. 10.1016/S0006-291X(05)80226-8 · DOI
  31. 10.1042/bj2220001 · DOI
  32. 10.1016/0016-5085(95)90149-3 · DOI
  33. 10.1002/hep.1840220522 · DOI
  34. Yoshikawa D, 1992, Circ. Shock, 38, 29
  35. 10.1073/pnas.91.17.7922 · DOI
  36. 10.1038/370218a0 · DOI
  37. 10.1006/bbrc.1994.2018 · DOI
  38. 10.1073/pnas.92.7.2815 · DOI
  39. 10.1093/oxfordjournals.jbchem.a124814 · DOI
  40. 10.1002/hep.1840130422 · DOI

Cited by

Sorted by citations

Metadata

Authors
Kaido, T., Yamaoka, S., Seto, S.-I., Funaki, N., Kasamatsu, T., Tanaka, J., Nakamura, T., & Imamura, M.
Affiliations
  • Kyoto University (JP)
  • The University of Osaka (JP)
Corresponding author
Yamaoka, Shoji
Venue
FEBS Letters
Publisher
Wiley
Published
1997-07-14
Volume
411
Issue
2-3
Pages
378-382
ISSN
  • 0014-5793 (ISSN-L)
  • 1873-3468
OpenAlex
W2114726053
Cited by
42
References
0
Citations by year
2025: 1 · 2021: 1 · 2017: 3 · 2016: 1 · 2014: 3 · 2013: 2 · 2012: 1
FWCI
3.04
Type
journal article
Language
en
Open access
closed
Locations
  • FEBS Letters (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Hepatology › Liver physiology and pathology
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Drug-Induced Hepatotoxicity and Protection
  • Health Sciences › Medicine › Surgery › Organ Transplantation Techniques and Outcomes
Keywords
hepatocyte growth factor, lipopolysaccharide, endotoxemia, liver injury, carbon tetrachloride, hepatoprotection, liver failure, aspartate aminotransferase, blood glucose
MeSH terms
Alanine Transaminase, Animals, Aspartate Aminotransferases, Carbon Tetrachloride, Endotoxins, Fibroblasts, Humans, Lipopolysaccharides, Liver, Male, Rats, Inbred F344, Recombinant Proteins, Spleen, Hepatocyte Growth Factor, Cell Transplantation, Endotoxemia, Rats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review